國立虎尾科技大學 |

Pharmaceutical Prices in the 21st Century

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Pharmaceutical Prices in the 21st Century/ edited by Zaheer-Ud-Din Babar.
other author:	Babar, Zaheer-Ud-Din.
Description:	X, 411 p. 37 illus., 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Health economics. -
Online resource:	https://doi.org/10.1007/978-3-319-12169-7
ISBN:	9783319121697

Pharmaceutical Prices in the 21st Century
Pharmaceutical Prices in the 21st Century[electronic resource] /edited by Zaheer-Ud-Din Babar. - 1st ed. 2015. - X, 411 p. 37 illus., 34 illus. in color.online resource.

Introduction -- Reference pricing strategies -- Differential pricing -- Prices of vaccines.

The book is an essential, comprehensive text onglobal drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total;nineteenof which are case studieson an array of high, middle, and low income countries. The final three chaptersdiscussvalue-based pricing, innovation, prices and the pharmaceutical industry and the link betweenpharmaceutical policy and pricing. As the pharmaceutical market continues to expand, a number of pharmaceutical pricing strategies have been employed to control drug expenditures. The book explores this phenomenon further and willserve a valuable resource for policy makers, funders, social insurance institutions and drug companies. About the author Zaheer-Ud-Din Babar, PhD is the Head of Pharmacy Practice at the School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a PhD in pharmaceutical policy, Dr Babar is a recipient of the prestigious “Research Excellence Award” from the University of Auckland. His research program covers areas related to pharmaceutical policy and practice, encompassing access to and affordability of medicines, issues related to medicine pricing and pharmacoeconomics. Dr Babar has delivered invited lectures at Boston University School of Public Health, Harvard Medical School, the Austrian Health Institute and the Universities of Reading and Kingston. He has also acted as a consultant for the World Health Organization, Health Action International, the International Union against Tuberculosis and Lung Disease, the International Pharmaceutical Federation (FIP) and the Pharmaceutical Management Agency of New Zealand in the area of medicines pricing and policies. Dr Babar is the Editor in Chief of the Journal of Pharmaceutical Policy and Practice, www.joppp.org and can be reached at z.babar@auckland.ac.nz.

ISBN: 9783319121697

Standard No.: 10.1007/978-3-319-12169-7doiSubjects--Topical Terms:

810102
Health economics.

LC Class. No.: RA410-410.9

Dewey Class. No.: 338.473621

Pharmaceutical Prices in the 21st Century
LDR:03336nam a22003975i 4500 001 963215
003 DE-He213
005 20200920091129.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319121697 $9 978-3-319-12169-7
024 7 $a 10.1007/978-3-319-12169-7 $2 doi
035 $a 978-3-319-12169-7
050 4 $a RA410-410.9
072 7 $a KCQ $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KCVJ $2 thema
082 0 4 $a 338.473621 $2 23
245 1 0 $a Pharmaceutical Prices in the 21st Century $h [electronic resource] / $c edited by Zaheer-Ud-Din Babar.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2015.
300 $a X, 411 p. 37 illus., 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- Reference pricing strategies -- Differential pricing -- Prices of vaccines.
520 $a The book is an essential, comprehensive text onglobal drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total;nineteenof which are case studieson an array of high, middle, and low income countries. The final three chaptersdiscussvalue-based pricing, innovation, prices and the pharmaceutical industry and the link betweenpharmaceutical policy and pricing. As the pharmaceutical market continues to expand, a number of pharmaceutical pricing strategies have been employed to control drug expenditures. The book explores this phenomenon further and willserve a valuable resource for policy makers, funders, social insurance institutions and drug companies. About the author Zaheer-Ud-Din Babar, PhD is the Head of Pharmacy Practice at the School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a PhD in pharmaceutical policy, Dr Babar is a recipient of the prestigious “Research Excellence Award” from the University of Auckland. His research program covers areas related to pharmaceutical policy and practice, encompassing access to and affordability of medicines, issues related to medicine pricing and pharmacoeconomics. Dr Babar has delivered invited lectures at Boston University School of Public Health, Harvard Medical School, the Austrian Health Institute and the Universities of Reading and Kingston. He has also acted as a consultant for the World Health Organization, Health Action International, the International Union against Tuberculosis and Lung Disease, the International Pharmaceutical Federation (FIP) and the Pharmaceutical Management Agency of New Zealand in the area of medicines pricing and policies. Dr Babar is the Editor in Chief of the Journal of Pharmaceutical Policy and Practice, www.joppp.org and can be reached at z.babar@auckland.ac.nz.
650 0 $a Health economics. $2 bicssc $3 810102
650 1 4 $a Health Economics. $3 786205
700 1 $a Babar, Zaheer-Ud-Din. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064944
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319121703
776 0 8 $i Printed edition: $z 9783319121680
776 0 8 $i Printed edition: $z 9783319350097
856 4 0 $u https://doi.org/10.1007/978-3-319-12169-7
912 $a ZDB-2-SBE
912 $a ZDB-2-SXEF
950 $a Business and Economics (SpringerNature-11643)
950 $a Economics and Finance (R0) (SpringerNature-43720)